Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage

被引：0
|
作者：
Olivier Bousiges
Nathalie Philippi
Thomas Lavaux
Armand Perret-Liaudet
Ingolf Lachmann
Caroline Schaeffer-Agalède
Pierre Anthony
Anne Botzung
Lucie Rauch
Barbara Jung
Paulo Loureiro de Sousa
Catherine Demuynck
Catherine Martin-Hunyadi
Benjamin Cretin
Frédéric Blanc
机构：
[1] University Hospital of Strasbourg,Laboratory of Biochemistry and Molecular Biology
[2] University of Strasbourg,Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA)
[3] CNRS UMR7364,CM2R (Research and Resources Memory Centre), Geriatric Day Hospital and Neuropsychology Unit, Geriatrics Department
[4] University Hospitals of Strasbourg,Neurochemistry Laboratory, Biochemistry Department, Centre de Biologie et Pathologie Est
[5] University of Strasbourg and CNRS,BIORAN Team, Lyon Neuroscience Research Center, CNRS UMR 5292
[6] ICube Laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), INSERM U1028
[7] Team IMIS,Center for Memory Resources and Research, Hospices Civils de Lyon
[8] Hospices Civils de Lyon,Geriatrics Department
[9] Université de Lyon - Université Claude Bernard,undefined
[10] Charpennes Hospital,undefined
[11] Lyon 1 University,undefined
[12] AJ Roboscreen GmbH,undefined
[13] General Hospital Centre,undefined
[14] CM2R,undefined
[15] Geriatric Day Hospital,undefined
来源：
Alzheimer's Research & Therapy | / 12卷
关键词：
Dementia with Lewy bodies; Alzheimer’s disease; Prodromal; Dementia; Cerebrospinal fluid biomarkers; Total alpha-synuclein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer's disease and dementia with Lewy bodies from the prodromal stage
    Bousiges, Olivier
    Philippi, Nathalie
    Lavaux, Thomas
    Perret-Liaudet, Armand
    Lachmann, Ingolf
    Schaeffer-Agalede, Caroline
    Anthony, Pierre
    Botzung, Anne
    Rauch, Lucie
    Jung, Barbara
    de Sousa, Paulo Loureiro
    Demuynck, Catherine
    Martin-Hunyadi, Catherine
    Cretin, Benjamin
    Blanc, Frederic
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [2] Diagnostic value of cerebrospinal fluid alpha-synuclein in dementia with Lewy body
    Bousiges, Olivier
    Blanc, Frederic
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2018, 16 (03): : 305 - 310
  • [3] Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice
    Lilamand, Matthieu
    Clery, Josue
    Vrillon, Agathe
    Mouton-Liger, Francois
    Cognat, Emmanuel
    Gaubert, Sinead
    Hourregue, Claire
    Martinet, Matthieu
    Dumurgier, Julien
    Hugon, Jacques
    Bouaziz-Amar, Elodie
    Paquet, Claire
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [4] Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage
    Bousiges, Olivier
    Bombois, Stephanie
    Schraen, Susanna
    Wallon, David
    Quillard, Muriel Muraine
    Gabelle, Audrey
    Lehmann, Sylvain
    Paquet, Claire
    Amar-Bouaziz, Elodie
    Magnin, Eloi
    Miguet-Alfonsi, Carole
    Delbeuck, Xavier
    Lavaux, Thomas
    Anthony, Pierre
    Philippi, Nathalie
    Blanc, Frederic
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (05): : 467 - 475
  • [5] Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
    Tateno, Fuyuki
    Sakakibara, Ryuji
    Kawai, Takayuki
    Kishi, Masahiko
    Murano, Takeyoshi
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2012, 26 (03): : 213 - 216
  • [6] Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies
    Bousiges, Olivier
    Cretin, Benjamin
    Lavaux, Thomas
    Philippi, Nathalie
    Jung, Barbara
    Hezard, Sylvie
    Heitz, Camille
    Demuynck, Catherine
    Gabel, Aurelia
    Martin-Hunyadi, Catherine
    Blanc, Frederic
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (04) : 1069 - 1083
  • [7] Detection of elevated levels of alpha-synuclein oligomers in cerebrospinal fluid from patients with Parkinson's disease and dementia with Lewy bodies
    Maetzler, W.
    Qureshi, M. M.
    Berg, D.
    Synofzik, M.
    Gasser, T.
    El-Agnaf, O. M. A.
    MOVEMENT DISORDERS, 2009, 24 : S40 - S40
  • [8] Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
    Perra, Daniela
    Bongianni, Matilde
    Novi, Giovanni
    Janes, Francesco
    Bessi, Valentina
    Capaldi, Stefano
    Sacchetto, Luca
    Tagliapietra, Matteo
    Schenone, Guido
    Morbelli, Silvia
    Fiorini, Michele
    Cattaruzza, Tatiana
    Mazzon, Giulia
    Orru, Christina D.
    Catalan, Mauro
    Polverino, Paola
    Bernardini, Andrea
    Pellitteri, Gaia
    Valente, Mariarosa
    Bertolotti, Claudio
    Nacmias, Benedetta
    Maggiore, Giandomenico
    Cavallaro, Tiziana
    Manganotti, Paolo
    Gigli, Gianluigi
    Monaco, Salvatore
    Nobili, Flavio
    Zanusso, Gianluigi
    BRAIN COMMUNICATIONS, 2021, 3 (02)
  • [9] Alpha-synuclein in the amygdala in Alzheimer's disease and dementia with Lewy bodies an immunohistochemical study.
    Kindelberger, D
    Sheffield, L
    Gearing, M
    Mirra, S
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (05): : 456 - 456
  • [10] Alpha-synuclein Levels in Cerebrospinal Fluid in Patients With Lewy Bodies Dementia and Other Neurodegenerative Disorders
    Kawada, Tomoyuki
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2021, 35 (02): : 187 - 187
12345